J. Palo

发表

AMYOTROPHIC LATERAL SCLEROSIS AND AUTONOMIC NERVOUS SYSTEM

M. Jokelainen, J. Palo, 1976, The Lancet.

Letter: Amyotrophic lateral sclerosis and autonomic nervous system.

M. Jokelainen, J. Palo, 1976, Lancet.

Increasing prevalence of multiple sclerosis in Finland

M. Hakama, J. Palo, P. Tienari, 2001, Acta neurologica Scandinavica.

Suspected dementia: evaluation of 323 consecutive referrals

T. Erkinjuntti, R. Sulkava, J. Palo, 1987, Acta neurologica Scandinavica.

Studies on N-aspartyl-β-glucosaminidase in aspartylglycosaminuria

J. Palo, H. Somer, H. Savolainen, 1975 .

Genomewide scan of multiple sclerosis in Finnish multiplex families.

M. Daly, E. Lander, L. Peltonen, 1997, American journal of human genetics.

The epidemiology of multiple sclerosis in Finland: increase of prevalence and stability of foci in high‐risk areas

J. Palo, E. Kinnunen, J. Wikström, 1983, Acta neurologica Scandinavica.

CSF in Alzheimer's disease: Studies on blood-brain barrier function and intrathecal protein synthesis

T. Erkinjuntti, J. Palo, I. Elovaara, 1985, Journal of the Neurological Sciences.

Toward understanding the pathogenic mechanisms in gelsolin-related amyloidosis: in vitro expression reveals an abnormal gelsolin fragment.

T. Paunio, L. Peltonen, J. Palo, 1994, Human molecular genetics.

Head injuries in Alzheimer's disease and vascular dementia

T. Erkinjuntti, R. Sulkava, J. Palo, 1985, Neurology.

High Levels of Brain Dolichols in Neuronal Ceroid‐Lipofuscinosis and Senescence

J. Palo, M. Haltia, L. Wolfe, 1983, Journal of neurochemistry.

Huntington disease in Finland: a molecular and genealogical study

L. Peltonen, J. Palo, E. Ikonen, 1992, Human Genetics.

Enrichment of high mannose-type glycans in nervous tissue glycoproteins in neuronal ceroid-lipofuscinosis

J. Palo, C. Maury, T. Krusius, 1986, Journal of the Neurological Sciences.

Hyperexcretion of free N-acetylneuraminic acid--a novel type of sialuria.

J. Palo, H. Rauvala, J. Finne, 1985, Clinica chimica acta; international journal of clinical chemistry.

Regional distribution of glycoasparagine storage material in the brain in aspartylglycosaminuria

J. Palo, M. Haltia, C. Peter, 1981, Journal of the Neurological Sciences.

Characterization of the storage material of peripheral lymphocytes in aspartylglycosaminuria.

J. Palo, P. Maury, 1980, Clinical science.

STUDIES ON THE CLUSTERING OF MULTIPLE SCLEROSIS IN FINLAND I: COMPARISON BETWEEN THE DOMICILES AND PLACES OF BIRTH IN SELECTED SUBPOPULATIONS

J. Palo, J. Wikström, 1975, Acta Neurologica Scandinavica.

CLINICAL AND NEUROPATHOLOGICAL FEATURES IN ALZHEIMER'S DISEASE

A. Paetau, R. Sulkava, J. Palo, 1982 .

Glial filaments are a major brain fraction in infantile neuronal ceroid-lipofuscinosis

A. Paetau, J. Palo, I. Virtanen, 2004, Acta Neuropathologica.

Protein composition of multiple sclerosis myelin.

P. Riekkinen, E. Kivalo, J. Palo, 1971, Archives of neurology.

Glucose tolerance in amyotrophic lateral sclerosis

J. Palo, K. Harno, A. Rissanen, 1984, Acta neurologica Scandinavica.

Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.

D. Neary, N. Sims, J. Palo, 1984, Journal of neurology, neurosurgery, and psychiatry.

Evidence for the presence of ‘Ouabain like’ compound in human cerebrospinal fluid

R. Rimón, J. Palo, J. Deutsch, 1985, Brain Research.

Presymptomatic DNA and MRI diagnosis of neurofibromatosis 2 with mild clinical course in an extended pedigree

L. Peltonen, O. Salonen, A. Palotie, 1995, Neurology.

Geographic and social distribution of patients with amyotrophic lateral sclerosis.

M. Jokelainen, J. Palo, 1977, Archives of neurology.

Serum amysoid A protein, albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome

J. Palo, C. Maury, I. Elovaara, 1986 .

CT Findings in Neuronal Ceroid Lipofuscinoses

J. Palo, R. Raininko, K. Sainio, 1990, Neuropediatrics.

Classic amyotrophic lateral sclerosis with dementia.

A. Paetau, R. Sulkava, J. Palo, 1982, Archives of neurology.

Huntington disease in Finland: linkage disequilibrium of chromosome 4 RFLP haplotypes and exclusion of a tight linkage between the disease and D4S43 locus.

L. Peltonen, J. Ott, A. Palotie, 1990, American journal of human genetics.

Monozygous twins discordant for amyotrophic lateral sclerosis.

M. Jokelainen, J. Palo, J. Lokki, 1978, European neurology.

GAS CHROMATOGRAPHIC SEPARATION AND MASS SPECTROMETRIC IDENTIFICATION OF POLYOLS IN HUMAN CEREBROSPINAL FLUID AND PLASMA

J. Palo, C. Servo, E. Pitkänen, 1977, Acta neurologica Scandinavica.

Polymerization of Gelsolin Variant Fragment in Tissue Causes Familial Amyloidosis, Finnish Type (FAF)

J. Palo, J. Ghiso, E. Levy, 1991 .

Immunocytochemical studies of Alzheimer neuronal perikarya with intermediate filament antisera

A. Paetau, J. Palo, V. Lehto, 1983, Journal of the Neurological Sciences.

Enzyme and protein studies of demyelination in diabetes

P. Riekkinen, J. Palo, E. Reske‐Nielsen, 1977, Journal of the Neurological Sciences.

Quantification of serum and cerebrospinal fluid gelsolin in familial amyloidosis, Finnish type (AGel)

T. Paunio, L. Peltonen, J. Palo, 1994 .

Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene

L. Peltonen, J. Palo, P. Tienari, 1993, The Lancet.

Finnish type of familial amyloidosis: cosegregation of Asp187----Asn mutation of gelsolin with the disease in three large families.

L. Peltonen, J. Palo, T. Heliö, 1991, American journal of human genetics.

Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin.

J. Palo, J. Ghiso, B. Frangione, 1990, The American journal of pathology.

Golli-MBP gene in multiple sclerosis susceptibility

L. Peltonen, A. Sajantila, T. Pastinen, 1998, Journal of Neuroimmunology.

Oligoclonal immunoglobulin bands in cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia

T. Erkinjuntti, R. Sulkava, J. Palo, 1988, Acta neurologica Scandinavica.

RAISED LEVELS OF CEREBRAL CORTEX DOLICHOLS IN ALZHEIMER'S DISEASE

J. Palo, M. Haltia, L. Wolfe, 1982, The Lancet.

N-Acetylglucosamine-asparagine levels in tissues of patients with aspartylglycosaminuria.

J. Palo, C. Maury, 1980, Clinica chimica acta; international journal of clinical chemistry.

A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease

A. Paetau, S. Lal, P. Wood, 1983, Journal of the Neurological Sciences.

Solid-phase minisequencing test reveals Asp187----Asn (G654----A) mutation of gelsolin in all affected individuals with Finnish type of familial amyloidosis.

T. Paunio, L. Peltonen, A. Syvänen, 1992, Genomics.

Amino acid composition of monomeric and polymeric human serum albumin.

J. Palo, A. Saifer, Jorma Palo, 1969, Analytical biochemistry.

Biochemical studies of CNS and PNS in human and experimental diabetes.

P. Riekkinen, J. Palo, E. Reske‐Nielsen, 1978, Advances in experimental medicine and biology.

Comparison between the proteins of human brain myelin in subacute sclerosing panencephalitis, Amyotrophic lateral sclerosis and malignant diseases.

E. Kivalo, J. Palo, H. Savolainen, 1973, Journal of the neurological sciences.

HLA antigens in Alzheimer's disease.

R. Sulkava, J. Palo, J. Wikström, 2008, Tissue antigens.

Protein composition of white matter myelin in subacute sclerosing panencephalitis

P. Riekkinen, E. Kivalo, J. Palo, 1971 .

Neuronal intranuclear inclusion disease

A. Tarkkanen, J. Palo, M. Haltia, 1986, Acta ophthalmologica.

PREVALENCE OF PHENYLKETONURIA AND SOME OTHER METABOLIC DISORDERS AMONG MENTALLY RETARDED PATIENTS IN FINLAND

J. Palo, 1967, Acta neurologica Scandinavica.

POLYOLS IN THE CEREBROSPINAL FLUID AND PLASMA OF NEUROLOGICAL, DIABETIC AND URAEMIC PATIENTS

J. Palo, C. Servo, E. Pitkänen, 1977, Acta neurologica Scandinavica.

Recent findings on some "new" neurometabolic diseases.

J. Palo, M. Haltia, P. Santavuori, 1976, Rivista di patologia nervosa e mentale.

Amyotrophic lateral sclerosis in Finland: Birthplaces of patients, parents and grandparents

M. Jokelainen, J. Palo, 1980, Acta neurologica Scandinavica.

Studies on the pathogenesis of multiple sclerosis. Basic proteins in the myelin and white matter of multiple sclerosis, subacute sclerosing panencephalitis and postvaccinal leucoencephalitis.

P. Riekkinen, E. Kivalo, J. Palo, 1971, European neurology.

Dolichols are elevated in brain tissue from Alzheimer's disease, but not in urinary sediment from Alzheimer's disease and Down's syndrome.

J. Palo, C. Bergeron, M. Kotila, 1985, Neurochemical pathology.

Biochemical studies on myelin isolated from the brains of patients with Down's syndrome.

J. Palo, N. Banik, A. Davison, 1975, Brain : a journal of neurology.

Cerebral aspergillosis with special reference to cerebrospinal fluid findings.

J. Palo, T. Uutela, M. Haltia, 1975, European neurology.

Dementia among medical inpatients. Evaluation of 2000 consecutive admissions.

T. Erkinjuntti, J. Palo, J. Wikström, 1986, Archives of internal medicine.

Neurofilament subunit–related proteins in neuronal intranuclear inclusions

J. Palo, S. Carpenter, M. Haltia, 1984, Annals of neurology.

Autonomic nervous system and cardiac involvement in familial amyloidosis, Finnish type (FAF)

E. Matikainen, J. Palo, M. Kupari, 1994, Journal of the Neurological Sciences.

FURTHER STUDIES ON THE EPIDEMIOLOGY OF MULTIPLE SCLEROSIS IN FINLAND

E. Kivalo, J. Palo, J. Wikström, 1973, Acta neurologica Scandinavica.

Thin-layer chromatographic demonstration of aspartylglycosylamine and a novel acidic carbohydrate in human tissues.

J. Palo, H. Savolainen, 1972, Journal of chromatography.

Dolichols in brain and urinary sediment in neuronad ceroid lipofuscinosis

J. Palo, L. S. Wolfe, J. Palo, 1983, Neurology.

The effect of high doses of synthetic ACTH on rat brain.

J. Palo, H. Savolainen, 1974, Brain research.

Dantrolene sodium in chronic spasticity of varying etiology

J. Palo, A. Nuutila, M. Luisto, 1982, Acta neurologica Scandinavica.

Serum and cerebrospinal fluid antibodies to cytomegalovirus in schizophrenia

R. Rimón, J. Palo, A. Ahokas, 1986, Acta psychiatrica Scandinavica.

Demonstration of fibronectin in human cerebrospinal fluid.

E. Ruoslahti, A. Vaheri, J. Palo, 1978, The Journal of laboratory and clinical medicine.

Leukocyte glutamate dehydrogenase and CSF amino acids in late onset ataxias

J. Palo, S. Kaakkola, S. Oja, 1990, Acta neurologica Scandinavica.

Leukocyte glutamate dehydrogenase and CSF amino acids in late onset ataxias

J. Palo, S. Kaakkola, S. Oja, 1990, Acta neurologica Scandinavica.

Eleven new cases of aspartylglucosaminuria.

J. Palo, K. Mattsson, 2008, Journal of mental deficiency research.

Studies on serum and urinary glycopeptides and glycosaminoglycans in aspartylglucosaminuria.

J. Palo, H. Savolainen, 1972, Clinica chimica acta; international journal of clinical chemistry.

Immune system genes in multiple sclerosis: genetic association and linkage analyses on TCRβ, IGH, IFN-γ and IL-1ra/IL-1β loci

L. Peltonen, T. Pastinen, J. Palo, 1997, Journal of Neuroimmunology.

Urinary sediment dolichols in the diagnosis of neuronal ceroid‐lipofuscinosis

F. Andermann, E. Andermann, J. Palo, 1986, Annals of neurology.

Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene

A Sajantila, L Peltonen, L. Peltonen, 1992, The Lancet.

Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings.

O. Salonen, J. Palo, P. Tienari, 1992, Journal of neurology, neurosurgery, and psychiatry.

Regional and Temporal Variation in the Incidence of Multiple Sclerosis in Finland 1979–1993

M. Hakama, J. Palo, P. Tienari, 2000, Neuroepidemiology.

CNS abnormalities in patients with familial amyloidosis, Finnish type (FAF)

O. Salonen, A. Seppäläinen, L. Hokkanen, 1994 .

Reappraisal of HLA in Multiple Sclerosis: Close Linkage in Multiplex Families

L. Peltonen, J. Partanen, J. Palo, 1993, European journal of human genetics : EJHG.

A follow-up study of very low field MRI findings and clinical course in multiple sclerosis

L. Ketonen, J. Palo, J. Wikström, 1988, Journal of the Neurological Sciences.

Mapping of the HLA Class II Susceptibility Haplotype for Multiple Sclerosis in Finland

L. Peltonen, U. Gyllensten, M. Allen, 2004 .

Studies on the geographic clustering of multiple sclerosis and optic neuritis in Finland

J. Palo, J. Wikström, 1976, Journal of Neurology.

SELENIUM, VITAMIN E AND COPPER IN MULTIPLE SCLEROSIS

J. Palo, J. Wikström, T. Westermarck, 1976, Acta neurologica Scandinavica.

DISTRIBUTION OF MULTIPLE SCLEROSIS IN FINLAND, WITH SPECIAL REFERENCE TO SOME GEOLOGICAL FACTORS

E. Kivalo, M. Panelius, J. Palo, 1966, Acta neurologica Scandinavica.

Infantile neuronal ceroid lipofuscinosis

J. Palo, M. Haltia, L. Wolfe, 1982, Neurology.

Dolichol and dolichyl phosphate in the neuronal ceroid-lipofuscinoses and other diseases.

J. Opitz, S. Gauthier, J. Palo, 1988, American journal of medical genetics. Supplement.

Two-locus linkage analysis in multiple sclerosis (MS).

J D Terwilliger, L Peltonen, L. Peltonen, 1994, Genomics.

Renal and Skin Biopsy Findings in Amyotrophic Lateral Sclerosis

Y. Collan, J. Palo, J. Lähdevirta, 1979 .

clinically affected and unaffected siblings . Familial multiple sclerosis : MRI findings in

J. Palo, P. Tienari, L. Valanne, 2022 .

Aetiological aspects of the cutis verticis gyrata and mental retardation syndrome.

J. Palo, K. Blomqvist, M. Iivanainen, 2008, Journal of mental deficiency research.

LOW PREVALENCE OF HUNTINGTONS-DISEASE IN FINLAND

L. Peltonen, J. Palo, E. Ikonen, 1900 .

LYSOSOMAL ENZYMES IN THE LYMPHOCYTES AND GRANULOCYTES OF PATIENTS WITH MULTIPLE SCLEROSIS

P. Riekkinen, J. Palo, I. Asikainen, 1977, Acta neurologica Scandinavica.

Studies on the Pathogenesis of Multiple Sclerosis

P. Riekkinen, E. Kivalo, J. Palo, 1971 .

Aspartylglycosaminuria: A generalized storage disease

J. Palo, M. Haltia, S. Autio, 1975, Acta Neuropathologica.

Bones hold the key to DNA virus history and epidemiology

P. Simmonds, A. Sajantila, J. Palo, 2015, Scientific Reports.

Glycoasparagine metabolites in patients with aspartylglycosaminuria: comparison between English and Finnish patients with special reference to storage materials.

J. Palo, H. Savolainen, R. Pollitt, 1973, Clinica chimica acta; international journal of clinical chemistry.

Tissue distribution and levels of gelsolin mRNA in normal individuals and patients with gelsolin‐related amyloidosis

T. Paunio, L. Peltonen, A. Syvänen, 1997, FEBS letters.

Amyloid protein in familial amyloidosis (Finnish type) is homologous to gelsolin, an actin-binding protein.

J. Palo, J. Ghiso, B. Frangione, 1990, Biochemical and biophysical research communications.

LOW PREVALENCE OF HUNTINGTON'S DISEASE IN FINLAND

L. Peltonen, J. Palo, E. Ikonen, 1987, The Lancet.

Haplotype analysis in gelsoiin‐related amyloidosis reveals independent origin of identical mutation (G654A) of gelsolin in Finland and Japan

T. Paunio, L. Peltonen, J. Weissenbach, 1995, Human mutation.

1-31-24 Immune system genes in multiple sclerosis: Genetic association and linkage analyses on TCRβ, IGH, IL-1ra/IL-1β and IFN-γ loci

L. Peltonen, T. Pastinen, J. Palo, 1997, Journal of the Neurological Sciences.

Neuronal intranuclear inclusion disease in identical twins

J. Palo, M. Haltia, W G Johnson, 1984, Annals of neurology.

Familial Amyloidosis, Finnish Type

A. Seppäläinen, J. Palo, M. Haltia, 1991 .

Free amino acids in Tay-Sachs and normal human brain gray matter.

J. Palo, A. Saifer, 1968, Clinica chimica acta; international journal of clinical chemistry.

The distribution of amyotrophic lateral sclerosis in Finland

M. Jokelainen, J. Palo, J. Wikström, 1975, Journal of the Neurological Sciences.

Urinary excretion of indican in progressive myoclonus epilepsy without lafora bodies The effect of sodium valproate

J. Palo, M. Koskiniemi, 1978, Journal of the Neurological Sciences.

URINARY EXCRETION OF INDICAN IN EPILEPSY WITHOUT LAFORA BODIES The Effect of Sodium Valproate PROGRESSIVE MYOCLONUS

J. Palo, M. Koskiniemi, 1978 .

Juvenile Metachromatic Leukodystrophy: Clinical, Biochemical, and Neuropathologic Studies in Nine New Cases

J. Palo, M. Haltia, A. Icén, 1980 .

Two cases with a ring chromosome in group E.

E. Kivalo, J. Palo, P. Aula, 2009, Acta neurologica Scandinavica.

ACCUMULATION OF GLYCOPROTEIN-DERIVED METABOLITES IN THE LIVER IN ASPARTYLGLYCOSAMINURIA

J. Palo, P. Maury, 1980 .

Maturation of myelin proteins in human brain.

P. Riekkinen, J. Palo, H. Savolainen, 1972, Brain research.

Prevalence of severe dementia in Finland

V. Lehtinen, A. Aromaa, R. Sulkava, 1985, Neurology.

TWO PATIENTS WITH A 46, XX, Er CHROMOSOME CONSTITUTION

E. Kivalo, J. Palo, J. Leisti, 1968, Acta paediatrica Scandinavica.

Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings.

A. Paetau, R. Sulkava, J. Palo, 1983, Journal of neurology, neurosurgery, and psychiatry.

Accuracy ofclinical diagnosis inprimarydegenerative dementia: correlation withneuropathologica l findings

A. Paetau, R. Sulkava, J. Palo, 1983 .

Neuropsychological differentiation between normal aging, Alzheimer's disease and vascular dementia

T. Erkinjuntti, R. Sulkava, J. Palo, 1986, Acta neurologica Scandinavica.

EEG in the differential diagnosis between Alzheimer's disease and vascular dementia

T. Erkinjuntti, R. Sulkava, L. Ketonen, 1988, Acta neurologica Scandinavica.

CT in the differential diagnosis between Alzheimer's disease and vascular dementia

T. Erkinjuntti, R. Sulkava, L. Ketonen, 1987, Acta neurologica Scandinavica.

The cover‐up of President Urho Kekkonen's dementia and its impact on the political life of Finland—a personal account 1

J. Palo, 1999, European journal of neurology.

dementia . histologically verified Alzheimer ' s cerebrospinal fluid of patients with concentrations in lumbar Monoamine metabolite

D. Neary, N. Sims, J. Palo, 2022 .

Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study.

A. Paetau, T. Erkinjuntti, R. Sulkava, 1988, Journal of neurology, neurosurgery, and psychiatry.

Raised Plasma Endothelin During Acute Migraine Attack

J. Palo, F. Fyhrquist, O. Saijonmaa, 1992, Cephalalgia.

The blessed dementia scale as a screening test for dementia

T. Erkinjuntti, R. Sulkava, L. Hokkanen, 1988 .

Malignant diseases among patients with multiple sclerosis

J. Palo, J. Wikström, J. Duchesne, 1977, Journal of Neurology.

EPIDEMIOLOGY OF NUTRITIONAL MUSCULAR DYSTROPHY AND MULTIPLE SCLEROSIS

E. Kivalo, J. Palo, J. Wikstköm, 1973 .

Serum amyloid A protein, albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome.

J. Palo, C. Maury, I. Elovaara, 1986, Acta neurologica Scandinavica.

Increased urinary excretion of glycerol: metabolic studies on a patient.

J. Palo, C. Servo, E. Pitkänen, 1977, Clinica chimica acta; international journal of clinical chemistry.

Myelination and Demyelination

J. Palo, Helsinki Finland Demyelination Recent Chemical Advances, 1978, Advances in Experimental Medicine and Biology.

The proteins of human myelin in inborn errors of metabolism and in chromosomal anomalies

J. Palo, J. Palo, H. Savolainen, 1973, Acta Neuropathologica.

Proteins of peripheral nerve myelin in diabetic neuropathy.

J. Palo, M. Haltia, H. Savolainen, 1972, Journal of the neurological sciences.

Proteins of human glial cell membrane

J. Palo, H. Savolainen, 1972, FEBS letters.

Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimer's disease and multi-infarct dementia.

T. Erkinjuntti, R. Sulkava, J. Palo, 1987, European neurology.

Arylsulphatase A and B in juvenile metachromatic leukodystrophy.

J. Palo, A. Icén, T. Haltia, 1979, Clinica chimica acta; international journal of clinical chemistry.

Platelet membrane fluidity in Alzheimer's disease and multi‐infarct dementia: a spin label study

T. Erkinjuntti, R. Sulkava, J. Palo, 1991, Acta neurologica Scandinavica.

Somatostatin-like immunoreactivity in lumbar cerebrospinal fluid from neurohistologically examined demented patients

D. Neary, P. Francis, J. Palo, 1984, Neurobiology of Aging.

White matter low attenuation on CT in Alzheimer's disease.

T. Erkinjuntti, R. Sulkava, L. Ketonen, 1989, Archives of gerontology and geriatrics (Print).

Pregnancy-Specific β1-Glycoprotein-Like Material in Human Cerebrospinal Fluid*

J. Palo, V. Lehto, M. Hurme, 1982 .

Effect of birthplace on the development of amyotrophic lateral sclerosis and multiple sclerosis

M Jokelainen, M. Jokelainen, J. Palo, 1979, Acta neurologica Scandinavica.

THE ROLE OF NEUROFILAMENTS IN THE FORMATION OF NEUROFIBRILLARY TANGLES

A. Paetau, J. Palo, V. Lehto, 1982 .

Immune system genes in multiple sclerosis: genetic association and linkage analyses on TCR beta, IGH, IFN-gamma and IL-1ra/IL-1 beta loci.

L. Peltonen, T. Pastinen, J. Palo, 1997, Journal of Neuroimmunology.

Neurofilament profile in olfactory mucosa of patients with a clinical diagnosis of Alzheimer's disease

R. Sulkava, J. Palo, S. Kaakkola, 2004, Virchows Archiv.

KIDNEY AND SKIN BIOPSY IN AMYOTROPHIC LATERAL SCLEROSIS

J. Palo, J. Lähdevirta, A. Rissanen, 1978, The Lancet.

The amino acid composition of gray matter ganglioside-peptides of normal human and Tay-Sachs brains.

J. Palo, A. Saifer, 1970, Clinica chimica acta; international journal of clinical chemistry.

Interferon therapy for ALS

K. Cantell, J. Palo, A. Rissanen, 1980, Annals of neurology.

Biogenic amine metabolites in the CSF of patients with late onset and alcoholic ataxias

J. Palo, S. Kaakkola, P. Tuomainen, 1993, Acta Neurologica Scandinavica.